Asia2G Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Celltriocelltrio.comJun 2025
Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation.
BiotechHardwareHealthtechRoboticsFremont, US
Charlie Duncheon(CEO & Cofounder)Jin-Oh Kim(CTO & Cofounder)Raphael Kim(VP, Software Engineering & Cofounder)inJeff Baird(Chief Operations Officer)inChau Chavez(CFO)
BoardMinbeom Kim(Director)
Co-investorsPremier Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.